RA Capital Management - CEREVEL THERAPEUTICS HLDNG I ownership

CEREVEL THERAPEUTICS HLDNG I's ticker is CEREW and the CUSIP is 15678U102. A total of 33 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RA Capital Management ownership history of CEREVEL THERAPEUTICS HLDNG I
ValueSharesWeighting
Q2 2021$3,358,000
+233.8%
233,3330.0%0.05%
+260.0%
Q1 2021$1,006,000
-23.7%
233,3330.0%0.02%
-16.7%
Q4 2020$1,318,000233,3330.02%
Other shareholders
CEREVEL THERAPEUTICS HLDNG I shareholders Q1 2021
NameSharesValueWeighting ↓
Affinity Asset Advisors, LLC 72,466$409,0000.22%
Altium Capital Management LP 64,666$365,0000.14%
Nantahala Capital Management 283,332$4,307,0000.13%
Governors Lane LP 196,034$1,108,0000.09%
SPHERA FUNDS MANAGEMENT LTD. 166,332$940,0000.08%
Monashee Investment Management LLC 99,998$565,0000.08%
Context Capital Management, LLC 85,967$486,0000.07%
BOOTHBAY FUND MANAGEMENT, LLC 75,400$1,250,0000.05%
Maven Securities LTD 56,667$338,0000.03%
Walleye Capital LLC 70,649$399,0000.03%
View complete list of CEREVEL THERAPEUTICS HLDNG I shareholders